Oncology Testing: Becoming More Effective, Specific, and Predictive
Advances in genomics and biomarker identification facilitate more accurate diagnoses for cancer patients.
Read MorePosted by Clinical Lab Products | Aug 16, 2010 | Cancer, Mass Spectrometry Reagents & Test Kits, Miscellaneous, Pancreatic |
Advances in genomics and biomarker identification facilitate more accurate diagnoses for cancer patients.
Read MorePosted by Clinical Lab Products | Aug 9, 2010 | Cancer, Miscellaneous |
Oncimmune (USA) LLC, provider of EarlyCDT-Lung, announces the publication of a study that demonstrates the clinical validity of the test.
Read MorePosted by Clinical Lab Products | Aug 4, 2010 | Miscellaneous |
BD Diagnostics announced that it has received “Moderate Complexity” status from the FDA, under the Clinical Laboratory Improvement Amendments (CLIA), for the BD MAX GBS Assay for Group B Streptococcus(GBS).
Read MorePosted by Clinical Lab Products | Aug 3, 2010 | Miscellaneous |
Correct coding of lab tests is critical to reimbursement and profitability.
Read MorePosted by Clinical Lab Products | Aug 1, 2010 | Miscellaneous, Respiratory Disease |
Molecular diagnostics are replacing culture as the gold standard but continue to share the stage with conventional methods.
Read More